Multidisciplinary Team Care for Breast Cancer
(TITAN Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Multidisciplinary team intervention for breast cancer?
Is multidisciplinary team care for breast cancer safe for humans?
How is the multidisciplinary team treatment for breast cancer different from other treatments?
The multidisciplinary team treatment for breast cancer is unique because it involves a group of healthcare professionals from different specialties working together to create a personalized care plan for each patient, ensuring a holistic approach to treatment. This collaborative method aims to provide seamless care across various stages of the disease, unlike traditional treatments that may not involve such comprehensive teamwork.1891011
What is the purpose of this trial?
People with breast cancer often experience many short and long-term side effects as a result of both the cancer and the necessary treatments.Receiving extra assessments and care from teams of multiple health professionals has been shown to be helpful for people with other health problems, such as heart disease. These 'multidisciplinary' teams may include nurses, doctors, pharmacists, dietitians, exercise therapists, counselors, and other specialists. Currently, the investigators do not know if receiving extra assessments from a multidisciplinary team is helpful for people receiving cancer treatment.In this study, the investigators hope to learn the effect of extra assessments and early interventions from teams of health care professionals in people diagnosed with cancer, during and after the treatment period.After initial assessments, participants will be randomized to multidisciplinary team intervention or usual care.
Eligibility Criteria
This trial is for adults over 18 with breast cancer or lymphoma, scheduled for specific chemotherapy treatments, and able to attend follow-ups. It's not for those with heart issues, prior thorax radiotherapy, previous similar chemo treatments, physical disability impeding certain tests, psychiatric conditions affecting consent, or involvement in related studies.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Assessment
Initial assessments conducted before randomization to intervention or usual care
Treatment
Participants receive either multidisciplinary team intervention or usual care
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Multidisciplinary team intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor